A GlaxoSmithKline logo is seen outside one of its buildings in west London in this February 6, 2008 file photograph. GlaxoSmithKline Plc has agreed to plead guilty to criminal charges and pay $3 billion to settle the largest case of healthcare fraud in ...
LONDON/BOSTON GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile pursuit of the U.S.
Two senior executives at GlaxoSmithKline Plc singled out by the U.S. Justice Department for pushing the Advair asthma drug for unapproved uses have moved on to some of Europe's top pharmaceutical companies.
GlaxoSmithKline GSK -0.72 % PLC's $3 billion criminal and civil settlement with the U.S. government this week raises questions about the future of asthma treatment Advair—the company's biggest moneymaker and one of the top-selling drugs in the world.